Literature DB >> 227563

Primary malignant giant cell tumor of bone: a study of eight cases and review of the literature.

A G Nascimento, A G Huvos, R C Marcove.   

Abstract

Eight cases of primary malignant giant cell tumor of bone were reviewed. There was a wide range in age from 17 to 76 years, with the sixth decade of life being the most common. The tumor was more frequent among females (male to female ratio--3:5). The most common sites of occurrence were in the region of the knee, with the distal end of femur and the proximal end of tibia affected in three and two cases, respectively. Pain and swelling of the involved regions were the most common complaints. The roentgenographic and pathologic features and the treatment were analyzed in detail. Although these cases were considered malignant, the follow-up periods varying from 4 to 15 years were available in six of the eight cases; only one patient died of tumor, 8 months after the surgical procedure. One patient died of unrelated cause, but the others were all alive with no evidence of disease. The pertinent literature was analyzed and examples of secondary malignant giant cell tumors of bone were compared to those of this present series to delineate differences in natural history and clinicopathologic features. It was clearly established that primary malignant giant cell tumor of bone is a separate entity with a more favorable clinical behavior, particularly if the disease process is eradicated early on either by cryosurgery, en bloc radical resection, or amputation.

Entities:  

Mesh:

Year:  1979        PMID: 227563     DOI: 10.1002/1097-0142(197910)44:4<1393::aid-cncr2820440433>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Case report 757: Giant cell tumor of rib.

Authors:  R M Hanna; M Kyriakos; S F Quinn
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

Review 2.  Giant cell tumour of bone: morphological, biological and histogenetical aspects.

Authors:  Mathias Werner
Journal:  Int Orthop       Date:  2006-09-30       Impact factor: 3.075

3.  Is bone graft necessary? Analysis of twenty cases of giant cell tumour of bone treated by curettage without graft.

Authors:  M A Waldram; R S Sneath
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

4.  Giant cell tumor of the infratemporal fossa.

Authors:  K Gibbons; A Singh; M A Kuriakose; T R Loree; K Harris; A Rubenfeld; S Goodloe; W L Hicks
Journal:  Skull Base Surg       Date:  2000

5.  Treatment and outcome of malignant giant cell tumor in the spine.

Authors:  Huabin Yin; Mo Cheng; Bo Li; Binbin Li; Peng Wang; Tong Meng; Jing Wang; Wang Zhou; Wangjun Yan; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-06-04       Impact factor: 4.130

6.  The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.

Authors:  Wendi O'Connor; Megan Quintana; Scott Smith; Monte Willis; Jordan Renner
Journal:  J Radiol Case Rep       Date:  2014-06-30

Review 7.  Surgical pathology of bone sarcomas.

Authors:  A G Huvos
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

Review 8.  Premalignant conditions of bone.

Authors:  Andrew Horvai; K Krishnan Unni
Journal:  J Orthop Sci       Date:  2006-07       Impact factor: 1.601

9.  Giant cell-rich osteosarcoma in long bones: clinical, radiological and pathological features.

Authors:  Cheng-Sheng Wang; Qi-Hua Yin; Jin-Sheng Liao; Jiang-Hua Lou; Xiao-Yi Ding; Yan-Bo Zhu
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

10.  [Giant cell tumor of bone with rapid malignant course].

Authors:  M R Lachat; M Weber; M D Cserhati; H P Honegger; A R von Hochstetter
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.